Compounds useful as modulators of the proteasome activity

Details Compounds useful as modulators of the proteasome activity Compounds useful as modulators of the proteasome activity

2011-04-05

2011-04-05

Russel, Jeffrey E (Department: 1654)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

C514S021100, C514S021900, C530S331000

Reexamination Certificate

active

07919468

ABSTRACT:
Compounds of the following general formula (I):are provided. The compounds can be used as modulators of the proteasome activity, in the preparation of a medicament useful for the prevention or treatment of diseases wherein the proteasome is involved, such as diseases of inflammatory processes, various hematological and solid tumor cancers, immunological and autoimmune diseases, cardiac pathologies, myopathies, AIDS, cystic fibrosis, Alzheimer's and Parkinson's disease, or in the preparation of cosmetic compositions or phytosanitary compositions.

REFERENCES:
patent: 0 248 231 (1987-12-01), None
patent: 0 818 462 (1998-01-01), None
patent: 0 832 900 (1998-04-01), None
patent: WO 02/081501 (2002-10-01), None
J. Adams. Potential for proteasome inhibition in the treatment of cancer. Drug Discovery Today. Apr. 2003, vol. 8, No. 7, pp. 307-315.
Berthelot, Alexandra et al:, “Synthesis of Macrocyclic Peptide Analogues of Proteasome Inhibitor TMC-95A” Journal of Organic Chemistry, 68(25) 9835-9838 Coden: JOCAH; ISSN: 0022-3263, 2003, XP002395076.
Kim Hanyoung et al:, “Solid-Phase Synthesis of Kojic Acid-Tripeptides and Their Tyrosinase Inhibitory Activity, Storage Stability, and Toxicity” Bioorganic & Medicinal Chemistry Letters, 14(11), 2843-2846 Coden:BMCLE8; ISSN: 0960-894X, 2004, XP002395077,. Abstract, Figure 1.
Koenig, Stephan et al:, “Dimerization Inhibitors of HIV-A Protease: Synthesis and Inhibitory Activity of Modified Peptides”, Innovations and Perspectives in Solid Phase Synthesis & Combinatorial Libraries: Peptides, Proteins and Nucleic Acids—Small Molecule Organic Chemistry Diversity, Collected Papers, International Symposium, 7thSouthampton, United Kingdom, Sep. 18-22, 2002, XP008065950 See Table 1.
Schramm H J et al:, The Inhibition of Human Immunodeficiency Virus Protease by Interface Peptides:, Antiviral Research, Elsevier Science BV., Amsterdam, NL, vol. 30, No. 2/3, 1996 pp. 155-170, XP000984896, ISSN: 0166-3542, Abstract; Table 1.
Kaiser Markus et al:, “The Core Structure of TMC-95A is a Promising Lead for Reversible Proteasome Inhibition”, Angewandte Chemie, International Edition, 41(5), 780-783, Coden: ACIFEF5; ISSN: 1433-7851, 2002, XP002395078.
Kaiser, Markus et al:, “Binding Mode of TMC-95A Analogues to Eukaryotic 20S Proteasome”, Chembiochem, 5(9), 1256-1266 Coden:, CBCHFX; ISSN: 1439-4227, 2004, XP002395079.
Kaiser, Markus et al:, “TMC-95A Analogues With Endocyclic Biphenyl Ether Group as Proteasome Inhibitors”, Chemistry & Biodiversity, 1(1), 161-173 Coden: CBHIAM; ISSN: 1612-1872, 2004, XP008065954.
Kaiser, Markus et al:, “Synthesis of a TMC-95A Ketomethylenen Analogue by Cyclization Via Intromolecular Suzuki Coupling”, Organic Letters, 5(19), 3435-3437 Coden: ORLEF7; ISSN: 1523-7060, 2003-XP002395080.
Kaiser, Markus et al:, “Synthesis of TMC-95A Analouges. Sturcture-Baseed Predicitonof Cyclization Propensities of Linear Precursors”, Letters in Peptide Science, Volume Date 2002, 9)2-3), 65-70 Coden: LPSCEM; ISSN: 0929-5666, 2003, XP002395081.
Takashi T et al:, “Structure-Activity Relation of Lwamide Peptides Synthesized With a Multipeptide Synthesizer”, Peptide Chemistry, Mino, Osaka, JP, 1996, pp. 193-196, XP002229806, ISSN: 0388-.3698 Table 2.
Rousseau, Patrice et al:, “Mechanism of Action of the .Alpha -Amylase Inhibitor (.Alpha.-AI1) of Kidney Bean: Use of Synthetic Peptides to Detect Regions of .Alpha.AI1 Interactiong With Pig Pancreatic .Alpha.-Amylase (PPA)”, Cost 98: Effects of Antinutrients on the Nutritional Value of Legume Diets, Proceedings of the Scientific Workshop, 2nd, 3rd, Budapest, Aberdeen UK, and Gozd Martuljek, Slovenia, 1995 and 1996, Meeting Date 1995, vol. 2, 13-16. Editor(s): Bardoc, 1996, XP008065957.
Salvadori, Sevvero et al:, “PHE3-Substituted Analogs of Deltorphin C. Spatial Conformation and Topography of the Aromatic Ring in Peptide Recognition by .Delta. Opiod Receptors”, Journal of Medicinal Chemistryk, 36 (24), 3748-56 Coden: JMCMAR; ISSN: 0022-2623, 1993, XP002395082.
Vavrek, Raymond J. et al:, “Selectivity of Minimum Sturcture Enkephalins”, Life Sciences, 31(20-21)M 2249-52 Coden: LIFSAK; ISSN: 0024-3205, 1982 XP002395083 Abstract; Compounds 8,25,26,28.

Affiliated with

Also associated with

Rating

Compounds useful as modulators of the proteasome activity does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compounds useful as modulators of the proteasome activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compounds useful as modulators of the proteasome activity will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2738595